1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Recombinant DNA Technology Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Medical
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Therapeutic Agent
6.1.2.2 Human Protein
6.1.2.3 Vaccines
6.1.3 Market Forecast
6.2 Non-Medical
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Biotech Crops
6.2.2.2 Specialty Chemicals
6.2.2.3 Others
6.2.3 Market Forecast
7 Market Breakup by Component
7.1 Expression System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloning Vector
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Food and Agriculture
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Health and Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Environment
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Biotechnology and Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Government Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Cibus
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F.Hoffmann-La Roche Ltd
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 GenScript
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlaxoSmithKline plc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Horizon Discovery Group plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 New England Biolabs
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novo Nordisk A/S
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi S.A
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Syngene International Ltd (Biocon Limited)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2023
Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2023
Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2023
Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2023
Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2023
Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2023
Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
Table 8: Global: Recombinant DNA Technology Market: Key Players